From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Summary and Comment

Racial Differences and Prognosis with LV Dysfunction

Mortality rates from congestive heart failure have been reported by some studies to be higher among blacks than whites. Investigators retrospectively analyzed data from the Studies of Left Ventricular Dysfunction (SOLVD) prevention and treatment trials to compare mortality rates of black and white subjects. Black trial participants were younger than white participants but had similar functional status and left ventricular (LV) ejection fraction. Mean follow-up was 32 to 34 months.

In multivariate analyses adjusted for age; sex; coexisting conditions; severity and etiology of heart failure; and medication use, blacks had higher mortality rates than did whites. In both the prevention (asymptomatic LV systolic dysfunction) and treatment (symptomatic LV systolic dysfunction) trials, blacks had a higher risk for death from all causes (RR, 1.36; 95 percent CI, 1.06-1.74 and RR, 1.25; 95 percent CI, 1.04-1.50, respectively), death from pump failure (RR, 1.57; 95 percent CI, 1.01-2.44 and RR, 1.32; 95 percent CI, 1.02-1.70, respectively), and death from any cause or hospitalization for heart failure (RR, 1.54; 95 percent CI, 1.27-1.88 and RR, 1.28; 95 percent CI, 1.10-1.49, respectively). This higher risk for blacks persisted after adjustment for socioeconomic differences.

Comment: These results confirmed that blacks have higher mortality rates with LV dysfunction but failed to explain the finding. The data suggest that differences in the quality of treatment and follow-up do not explain the racial differences in outcomes.

— HM Krumholz

Published in Journal Watch Cardiology April 9, 1999

Citation(s):

Dries DL et al. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 1999 Feb 25 340 609-616.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1999. Massachusetts Medical Society. All rights reserved.